The study, published in Alzheimer’s & Dementia, showed that having a biological age older than chronological age is associated with a greater likelihood of developing dementia, particularly vascular dementia, and with an earlier age of onset across dementia subtypes.
University of California, Irvine researchers have invented a wearable, wireless, battery-free, bioelectronic sensor to monitor users’ health by analyzing molecular biomarkers in human sweat.
A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought.
Using ultrasound to stimulate a specific part of the brain could offer a noninvasive therapy that benefits those experiencing chronic pain, a new study has suggested.
The body can notice stress before the conscious brain — and that’s no lie
Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical partners, have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.
A new way to detect the onset of heart and kidney disease far earlier than previously possible has been discovered by scientists. The breakthrough, published today in Nature Communications, reveals a novel method for identifying damage to the lining of microscopic blood vessels.
Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer. The technology, which aims to bring high-resolution, real-time diagnostics directly to the point of care, was recently described in a paper published in the Proceedings of the National Academy of Sciences.
Now, a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) has developed a new type of CAR T cell therapy that targets a protein found almost exclusively on leukemia cells and not on healthy cells.
Researchers at Washington University School of Medicine in St. Louis, showed that a stem cell transplant in which the donor cells have been genetically engineered to remove a particular protein helps prevent toxic side effects and potentially improves the effectiveness of therapies given after a transplant to help prevent cancer recurrence.